Skip to content

Comparative efficacy of 1% sodium alendronate gel V/s cissus quadrangularis capsules on stability and crestal bone loss of dental implants : A randomized control trial.

To compare the effectiveness of 1% sodium alendronate gel V/s cissus quadrangularis capsules on stability and crestal bone loss of dental implants : A randomized control trial.

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/09/057185
Enrollment
24
Registered
2023-09-01
Start date
Unknown
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K081- Complete loss of teeth Health Condition 2: K084- Partial loss of teeth

Interventions

None listed

Sponsors

Dr Ankita Chhabrani
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients being in need of at least one dental implant. 2. Patients exhibiting adequate bone quality and quantity, 3. Have had extractions done at least 3 months prior to implant placement. 4.Consenting patients who are cooperative and able to come for regular follow up.

Exclusion criteria

Exclusion criteria: 1. Untreated caries and/or periodontal disease of residual dentition. 2. History of pain in TMJ. 3. Patients who will undergo occlusal adjustments therapy, composite restorations, orthodontic treatment, extraction. 4. Need for presurgical bone and soft tissue augmentation in the planned implant area. 5. Any systemic or local disease or condition, & under medication that would compromise postoperative healing and or osseointegration. 6. Present alcohol or drug abuse. 7. Current use of smoke or smokeless forms of tobacco. 8. Pregnancy or lactation at the time of enrollment.

Design outcomes

Primary

MeasureTime frame
To compare the clinical and radiographical parameters around implants.Timepoint: Baseline, post- implant placement, 2,4,8,12th week

Secondary

MeasureTime frame
To compare the implant stability quotient in all groups.Timepoint: Baseline, post- implant placement, 2,4,8,12th week

Countries

India

Contacts

Public ContactDr Ankita Chhabrani

JSS DENTAL COLLEGE AND HOSPITAL

dr.avinashbs@jssuni.edu.in9945047223

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026